This volume provides readers with the most updated scientific information on the efficacy and safety of medicines for children and adolescents. The book enriches the understanding of pediatric pharmacotherapy for health professionals, regulatory agencies, pharmaceutical companies and learned societies. It contains important information on the pharmacodynamics and pharmacokinetics of drugs. It summarizes the latest investigations on the effects of pharmacological treatments in relation to and dependent on age, gender, fat mass and disease status. Therefore and importantly, this volume reviews the latest data on how pharmacotherapy has to be adjusted and personalized in regards to stages of development and during the pediatric lifespan from neonate through adolescence. In addition, the topic of rare diseases and special challenges for pharmacotherapy will be included and will provide readers with the necessary knowledge to handle complex diseases and treatment strategies especially in relation to pharmacotherapy of rare and orphan diseases.

Increase your understanding of pharmacotherapy prescribed to pediatric patients with these realistic case studies.

Now there is a very effective way to assess and advance your pediatric pharmacotherapy skills, on your own time, at your own pace: ASHP’s new Pediatric Pharmacotherapy Self Assessment. Sandra Benavides and Milap C. Nahata, co-lead editors of a major pediatric pharmacotherapy textbook, and Hanna Phan, Assistant Professor of Pharmacy Practice & Science and Pediatrics at The University of Arizona, Colleges of Pharmacy and Medicine, have created this unique resource. A practical learning tool for all levels of proficiency, it allows students, residents, and practicing pharmacists alike to strengthen their knowledge and analytical skills through 32 cases involving varying degrees of diagnostic complexity. Based on real life situations, these cases present challenges in the use of supplements, OTC, drug formulations, and all other therapies for neonates, children, and adolescents. This Self Assessment is a professional development tool for all areas of concern and levels of practice that can benefit you and your youngest patients for years to come.

For more than two decades, Pediatric Injectable Drugs (The Teddy Bear Book), has served an important and continuing need for reliable evidence-based information specific to pediatric injectable drugs. The tenth edition of this invaluable reference has grown to cover 238 drugs commonly used in the treatment of infants and children, including 20 new to this edition.

There are few publications about chemotherapy in children, and none of them is a book aimed at pharmacists. Pediatric Oncology Pharmacy is an area where more and more specific knowledge is required in daily practice. Pharmacists who work in pediatric oncology area do not have a book directed at them; none of the oncopediatric books addresses topics unique to pharmacy — such as manipulation of cytotoxic drugs for children, analysis of oncopediatric prescriptions, clinical pharmacy in oncopediatrics, pharmaceutical care in oncopediatric area, and other subjects that are of exclusive interest to these professionals, but no less essential for a therapy of excellence. As for this need, the purpose of this book is to be a guideline for all subjects that pediatric oncology pharmacists need to know to work in this area. It will be an essential guide to pediatric oncology pharmacists, clinical pharmacists, pharmaceutical residents who work with drug therapy in children and pharmaceutical researchers. It will be a pocket guide to assist in daily practice, and it will be essential to Pediatric Oncology/ Hematology Institutions. The essential propose of this book is to be the first one focusing pediatric oncology for pharmacists.